Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antihypertensive drugs >  Fimasartan

Fimasartan

Basic information Safety Supplier Related

Fimasartan Basic information

Product Name:
Fimasartan
Synonyms:
  • 2-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one
  • Fimasartan
  • Unii-p58222188p
  • 2-(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrim
  • 2-(2-butyl-4-Methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-1,6-dihydropyriMidin-5-yl)-N,N-diMethylethanethioaMide
  • 2-(2-butyl-4-Methyl-6-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methoxy)pyriMidin-5-yl)-N,N-diMethylacetaMide-yl)-N,N-diMethylacetaMide
  • BR-A-657
  • Kanarb
CAS:
247257-48-3
MF:
C27H31N7OS
MW:
501.65
EINECS:
207-981-6
Product Categories:
  • Inhibitors
  • API
Mol File:
247257-48-3.mol
More
Less

Fimasartan Chemical Properties

Melting point:
>155°C (dec.)
Boiling point:
693.0±65.0 °C(Predicted)
Density 
1.25
storage temp. 
2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
pka
4.16±0.10(Predicted)
color 
White to Off-White
More
Less

Fimasartan Usage And Synthesis

Description

Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and heart failure. It has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials. Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the brand name Kanarb by Boryung Pharmaceuticals.

Uses

Fimasartan is a new angiotensin II receptor blocker antagonist and also functions as an antihypertensive agent.

Definition

ChEBI: Fimasartan is a member of biphenyls.

Biological Activity

Fimasartan (Kanarb) is a non-peptide angiotensin II receptor antagonist (ARB) with noncompetitive, insurmountable binding with the AT1 receptor. It is used for the treatment of hypertension and heart failure.

Mechanism of action

Angiotensin II activates AR1 leading to vasoconstriction and increased noradrenaline release which further increases vasoconstriction via action at α1-adrenergic receptors. It also stimulates secretion of aldosterone which acts to increase sodium and water reabsorption in the renal tubules. Fimasartan bind to and antagonizes AR1 preventing vasoconstriction and reducing aldosterone secretion to increase natriuresis leading to a reduction in blood volume. Together these effects produce an anti-hypertensive effect.

FimasartanSupplier

Nanjing Lift Pharmaceutical Technology Co., Ltd. Gold
Tel
18951933883
Email
leo.feng@liftpharm.com
Jiangxi ravel Biotechnology Co.,Ltd Gold
Tel
18502762009
Email
721846333@qq.com
Zhuhai Hairuide Bioscience and Technology Co., Ltd Gold
Tel
0756-7789199 13326687259
Email
sales@zhhairuide.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
zhangsn@titansci.com